Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lo

Showing results (321-330 of 386) with videos related to

Pageof 39
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 2, 2021
Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapyAdriana Hepner, Victoria G Atkinson, James Larkin, et al.
NPJ Precision Oncology|January 22, 2026
Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanomaYizhe Mao, Tuba N Gide, Nigel G Maher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanomaA M Menzies, S N Lo, R P M Saw, et al.
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2024
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastasesInes Pires da Silva, Isabel Li, Selma Ugurel, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
The Lancet. Oncology|March 28, 2024
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysisRobert C Stassen, Carolien C H M Maas, Astrid A M van der Veldt, et al.
JAMA|August 2, 2022
Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical TrialMatthew K Bagg, Benedict M Wand, Aidan G Cashin, et al.
Scientific Data|August 2, 2024
The Human Connectome Project of adolescent anxiety and depression datasetN A Hubbard, C C C Bauer, V Siless, et al.
Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.
Pageof 39

Showing results (321-330 of 386) with videos related to

Sort By:
Pageof 39
European Journal of Cancer (Oxford, England : 1990)|July 2, 2021
Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapyAdriana Hepner, Victoria G Atkinson, James Larkin, et al.
NPJ Precision Oncology|January 22, 2026
Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanomaYizhe Mao, Tuba N Gide, Nigel G Maher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanomaA M Menzies, S N Lo, R P M Saw, et al.
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2024
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastasesInes Pires da Silva, Isabel Li, Selma Ugurel, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
The Lancet. Oncology|March 28, 2024
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysisRobert C Stassen, Carolien C H M Maas, Astrid A M van der Veldt, et al.
JAMA|August 2, 2022
Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical TrialMatthew K Bagg, Benedict M Wand, Aidan G Cashin, et al.
Scientific Data|August 2, 2024
The Human Connectome Project of adolescent anxiety and depression datasetN A Hubbard, C C C Bauer, V Siless, et al.
Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.
Pageof 39